Followers | 376 |
Posts | 17100 |
Boards Moderated | 4 |
Alias Born | 03/07/2014 |
![](https://investorshub.advfn.com/uicon/458287.png?cb=1657037051)
Friday, August 17, 2018 3:44:00 PM
THAT is the standard play book for TOXIC CONVERTIBLE DEBT DILUTION PAPER PRINTER PLAYS LIKE THIS ONE.......
Their biggest round of TOXIC NOTES (inked in April and May - totally around $500K) can start being converted around Sept....after the 6 month pre-pay option expires...and CELZ has NO CASH to pre-pay that amount of notes so the note holders will then begin to convert in tranches...one after another after another usually with SHORTING in cycles to drive their conversion price as low as possible...just as these RIPS DOWN to .0250 or so are doing now...
Thus...as the price becomes 2 CENTS OR SO which is where it's headed soon..the Sr Mgt will IMO do a REVERSE SPLIT to "try" and keep the disaster of the TOXIC NOTE CONVERSION from driving um to ONE CENT or even SUB ONE CENT...
I'd "guess" probably a nice 1-for-50 or so REVERSE SPLIT to take the share price back around $1 buck each...and then it will get RE-DILUTED RIGHT BACK DOWN TO PENNIES in short order....if I've seen it once with TOXIC DEBT then I've seen it a 1000 times... especially as TOXIC as these horrific notes are they are signing- good gawd, 60% discount to face and 20 day pre-conversion periods...holy cow....
It ain't gonna be pretty going forward...FUGLY-UGLY as they print shares like toilet paper....STEEPLY DISCOUNTED and every last one going to the SELL-SIDE of the equation...
LOOK...the dudes running this CLOWN CAR didn't authorize 3 BILLION SHARES recently for nothing...they know what they are signing on those notes and what it does to the common share price...TOILET PAPER....MASS DILUTION that pours shares out like water going over Niagra Falls...by the next 10-Q...they'll have blown past 1 BILLION SHARES OUTSTANDING....EASY...and will still be climbing like a bat out of hell....
Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.
Recent CELZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM